WCC-2022

★ Scientific Program

Preliminary Program

Track 1-7: Tumor Microenvironment

Time: 09:00-12:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: Stem Cell in the Colon Tissue Regeneration Dr. Yan Li, Principal Project investigator, Cleveland Clinic, USA
09:30-09:55		Speech Opportunity Available Abstract and Biography: Submit Here
09:55-10:20		Speech Opportunity Available Abstract and Biography: Submit Here
10:20-10:45		Title: Tumor Microenvironment Based HCC-targeting Gene Therapy throughout In Vivo Immunogenic Cell Death in Immunocompetent Mouse Dr. Jin Sook Jeong, Professor, Dong-A University Medical School, South Korea
10:45-11:00	Coffee Break
11:00-11:25		Title: Human RNASET2: A Highly Pleiotropic Tumor Suppressor Gene Involved in Establishing a Complex Crosstalk between Cancer Cells and the Tumor Microenvironment Dr. Francesco Acquati, Associate Pofessor, University of Insubria, Italy
11:25-11:50		Title: The Role of ECM Signaling in Cancer Dr. D. Nikitovic, Associate Professor, University of Crete, Greece
11:50-12:15		Title: Cell of Origin And Its Growth Regulation Are Essential in Cancer Dr. Helge L. Waldum, Professor, Trondheim University Hospital, Norway
12:15-12:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 1-8: Cancer Bioinformatics and Systems Biology

Time: 14:00-17:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Dr. Magnus S Magnusson, Founder & Director of Human Behavior Laboratory, University of Iceland, Iceland
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: Sudden Self-similarity between Protein to Human Mass-Societies with A Revolution in Lifestyle: T-Patterns, T-Strings and Structural and Functional Analogies between the RNA and Textual Words Dr. Magnus S Magnusson, Founder & Director of Human Behavior Laboratory, University of Iceland, Iceland
14:30-14:55		Title: Bio-inspirations of Cell Pulsations and Their Application to Inhibition of the Proliferation of Cancer Cells Dr. Shujun Zhang, Key Laboratory of Bionic Engineering (Ministry of Education), College of Biological and Agricultural Engineering, Jilin University, China
14:55-15:20		Title: TBD Dr. Rodrigo Mora, Professor, University of Costa Rica, Costa Rica
15:20-15:45		Speech Opportunity Available Abstract and Biography: Submit Here
15:45-16:00	Coffee Break

Track 2-4: Cancer Molecular Imaging and Nuclear Oncology

Time: 09:00-12:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Dr. Robert L. Bard, Director, Bard Cancer Diagnostics, USA
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: Factors Determining Cancer Aggression and Treatment Outcome: Skin, Breast and Prostate Dr. Robert L. Bard, Director, Bard Cancer Diagnostics, USA
09:30-09:55		Title: Diagnostic Accuracy of Tomosynthesis (DBT) VsMagnetic Resonance Imaging (MRI) and Mammography (DM) in Assessing Breast Tumor Size; A Preliminary Evaluation on 60 Female Patients Dr. Annunziata Russo, Department of Radiology, Ospedale Monsignor Raffaele Dimiccoli, Italy
09:55-10:20		Title: The Role of MSCT in Assessing the Response to Neoadjuvant Chemotherapy and Determining the Possibility of Radical Surgery Dr. Sidorova Julia, Radiologist, Radiology Research and Practical Centre, Russia
10:20-10:45		Speech Opportunity Available Abstract and Biography: Submit Here
10:45-11:00	Coffee Break
11:00-11:25		Title: Understanding 1st Ray Instability of the Foot Dr. Pasquale Cancelliere, Fellowship Director, Lower Extremity Research Institute, USA
11:25-11:50		Title: Role of DCEB-MRI (Dynamic contrast enhanced Breast MRI) In Diagnosis and Staging of Cancer Breast Dr. Manar Talaat EL-Essawy, Royal College, UK
11:50-12:15		Title: Role of DCEB-MRI (Dynamic contrast enhanced Breast MRI) in cancer breast Dr. Manar Talaat EL-Essawy, Royal College, UK
12:15-12:40		Title: Infrared Spectroscopy to Diagnose Metastatic Potential Dr. Yosef Raichlin, Ariel University, Israel

Track 2-5: Liquid Biopsies: Cell-Free DNA and Circulating Tumor Cells

Time: 09:00-12:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Speech Opportunity Available Abstract and Biography: Submit Here
09:30-09:55		Speech Opportunity Available Abstract and Biography: Submit Here
09:55-10:20		Speech Opportunity Available Abstract and Biography: Submit Here
10:20-10:45		Speech Opportunity Available Abstract and Biography: Submit Here
10:45-11:00	Coffee Break

Track 2-6: Artificial Intelligence in Cancer Diagnostics

Time: 14:00-16:00, November 22, 2022 (Sunday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Speech Opportunity Available Abstract and Biography: Submit Here
14:55-15:20		Speech Opportunity Available Abstract and Biography: Submit Here
15:20-15:45		Speech Opportunity Available Abstract and Biography: Submit Here
15:45-16:00	Coffee Break

Track 2-7: Lab on a Chip and Microarrays

Time: 14:00-17:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Speech Opportunity Available Abstract and Biography: Submit Here
14:55-15:20		Title: Single-cell Microarray Chip System for Separation, Analysis and Retrieval of Different Types of Cancer Cells Dr. Shohei Yamamura, National Institute of Advanced Industrial Science and Technology (AIST), Japan
15:20-15:45		Title: High Sensitivity Detection of Cystatin C Using High Refractive Index Photonic Crystal Sensor Dr. Yoshinori Akagi, Sekisui Chemical Co., Ltd., Japan
15:45-16:00	Coffee Break

Track 2-8: Molecular Pathology/Cytopathology Approaches, Tissue and Cell-based Cancer Diagnostics

Time: 14:00-17:40, November 22, 2022 (Sunday); Place: Lisbon, Portugal

Chair: Dr. Ryan S. Robetorye, Director, Mayo Clinic in Arizona, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title : Pulmonary lymphangioleiomyomatosis: A Proposed State of Neoplastic Senescence Dr. Charles Lombard, A Anatomic Pathology Specialist, El Camino Health, USA
14:30-14:55		Title: Diagnosis of Salivary Gland Tumors From Morphology to Molecular Markers Dr. Qihui (Jim) Zhai, Professor, Director of FISH Laboratory, Mayo Clinic, USA
14:55-15:20		Title: A Sensitive Single-Visit Cervical Screening Using Pap Test and Visual Inspection Enabling Same-day biopsy in Low-Resource Communities Dr. Wen Jie Zhang, Professor, Shihezi University School of Medicine,China
15:20-15:45		Title: Upregulated Cyclin A1 and CCNA1 Gene as Diagnostic Biomarkers in Papillary Thyroid Carcinoma Dr. Renata A. Canevari, Laboratório de Biologia Molecular do Câncer (Laboratory of Cancer Molecular Biology), Brazil
15:45-16:00	Coffee Break
16:00-16:25		Title: TBD Dr. David Hernandez Gonzalo, University of Florida, USA
16:25-16:50		Title: TBD Dr. Anwar Al-Banaw, Assistant Professor, Kuwait University, Kuwait
16:50-17:15		Speech Opportunity Available Abstract and Biography: Submit Here
17:15-17:40		Title: Gene Expression Profiling of Large B-Cell Lymphomas Using Formalin-Fixed Paraffin-Embedded Tissue Specimens in a Clinical Molecular Diagnostics Laboratory Dr. Ryan S. Robetorye, Director, Mayo Clinic in Arizona, USA

Track 3-7: Cancer Biotherapies

Time: 09:00-12:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Speech Opportunity Available Abstract and Biography: Submit Here
09:30-09:55		Title: Plant Macromolecule from Different Species of Boraginaceae Family, Its Synthetic Monomer and Their Anticancer Efficacy Dr. Vakhtang Barbakadze, Head of Department of Plant Biopolymers, Tbilisi State Medical University Institute of Pharmacochemistry, Georgia
09:55-10:20		Title: TBD Dr. Daniel Emerling, Senior Vice President, Atreca, Inc., USA
10:20-10:45		Title: Reprogramming of CAR-NK Cells to Enhance Cytotoxicity for Pancreatic Cancer Treatment Dr. Mihue Jang, Senior Research Scientist, Korea Institute of Science and Technology (KIST), South Korea
10:45-11:00	Coffee Break

Track 3-8: Combination Therapy, Complementary and Alternative Medicine

Time: 14:00-17:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Title: Healing By Ozone Therapy, A Naturopathic Approach Dr. Chun-Ming Lin, Consultant, Quantum Health Center, USA
14:55-15:20		Speech Opportunity Available Abstract and Biography: Submit Here
15:20-15:45		Title: Pytochemicals as Adjuvants in Cancer Treatments Dr. María Amanda Casillas Rivera, Universidad Iberoamericana, Mexico
15:45-16:00	Coffee Break
16:00-16:25		Title: Fuzheng Xiaoliu Granules combined with comprehensive Minimally Invasive Treatment for 75 Cases of Primary Liver Cancer Ms. Dongfang Shang,First Affiliated Hospital of Henan University of TCM, China
16:25-16:50		Title: Risk Related Therapy in Meta-Analyses of Critical Care Interventions: Bayesian Meta-Regression Analysis Dr. John moran, The Queen Elizabeth Hospital, Australia
16:50-17:15		Title: 1,25-DihydroxyvitaminD and Sodium Valporate Enhance the Sensetivity of Prostate Cancer Cells to Ionizing Radiation Dr. Shraga Shany, Professor, Ben Gurion University, Israel
17:15-17:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 4-4: Anticancer Drugs from TCM and Natural Products

Time: 09:00-12:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Dr. Dongfeng Tan,Professor, The University of Texas M. D. Anderson Cancer Center, USA
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: New Challenges and Opportunities of Cancer Immunotherapy Dr. Dongfeng Tan,Professor, The University of Texas M. D. Anderson Cancer Center, USA
09:30-09:55		Title: TBD Dr. Weiling Li, Professor, Dalian Medical University, China
09:55-10:20		Title: Triterpenes Derived from Plants as New Prominent Therapeutic Agents Dr. Leda Guzmán, Director, Laboratory of Biomedicine and BiocatalysisIstituto de Química. Pontificia Universidad Católica de Valparaiso, Chile
10:20-10:45		Titlle: Rubus and Vaccinium Mediated Photodynamic Therapy in Breast Cancer Cells Dr. Blassan Plackal Adimuriyil George, Researcher, University of Johannesburg, South Africa
10:45-11:00	Coffee Break
11:00-11:25		Title: Astragalus Polysaccharide Ameliorates Colitis Associated Colorectal Cancer in Mice Via Suppressing Bacterial Induced Inflammatory Responses And Epithelial-Mesenchymal Transition Dr. Leilei Liu, Postdoctor, Beijing University of Chinese Medicine, China
11:25-11:50		Speech Opportunity Available Abstract and Biography: Submit Here
11:50-12:15		Title: TBD Dr. Bin Lu, Researcher, Wenzhou Medical University, China
12:15-12:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 5-7: Genitourinary Cancer

Time: 09:00-12:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Dr. Hiten R H Patel, Director, University of Tromso, Norway
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: Big tumors, small samples: Subclassification of Renal Cell Carcinoma in Cytology Specimens, in the Age of Declining Nephrectomies, Targeted Therapies and Expanding Entities Dr. Valentina Robila, Virginia Commonwealth University School of Medicine, USA
09:30-09:55		Title: The Invisibility of Occupational Diseases: The Relationship Between Working Conditions and the Diagnosis of Prostate Cancer Dr. Liliana Cunha, Assistant Professor, Faculdade de Psicologia e Ciências da Educação da Universidade do Porto, Portugal
09:55-10:20		Title: TBD Dr. Chris Protzel, Professor, Helios Kliniken Schwerin, Germany
10:20-10:45		Title: The Story of Mitotic Kinase in VHL Disease Dr. Y Arlot-Bonnemains, Université de Rennes, France
10:45-11:00	Coffee Break
11:00-11:25		Title: Cancer/Testis Antigens into Mitochondria: A Hub Between Spermatogenesis, Tumorigenesis and Mitochondrial Physiology Adaptation Dr. Salim Khiati, Assistant Professor, Angers University, France
11:25-11:50		Title: Does Spontaneous Renal Hemorrhage Mandate Close Surveillance for Impending Renal Cell Carcinoma? Dr. Hamad Alakrash, Prince Sultan Military Medical City, Saudi Arabia
11:50-12:15		Title: Investigation of Cytotoxic Effect of Hemocyanins Against ��24 Bladder Carcinoma Permanent Cell Line Dr. Lyudmila Velkova, Bulgarian Academy of Sciences, Bulgaria
12:15-12:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 5-8: Hematologic Malignancies

Time: 09:00-12:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Dr. Ros Hastings, Scheme Director, Oxford University Hospitals, UK Co-chair: Dr. Hong Chang, Professor, University of Toronto, Canada
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Title: Quality Assurance in Haematological Neoplasms Dr. Ros Hastings, GenQA Consultant,Oxford University Hospitals NHS Foundation Trust, UK
09:30-09:55		Title: Importance of Stem Cell Presence in Leukemias: Immunophenotyping, Prognosis And Therapeutics Dr. Alice Teixeira Ferreira, Universidade Federal de São Paulo, Brazil
09:55-10:20		Title: TBD Dr. Charalampia Kyriakou, Consultant Haematologist, University College London, UK
10:20-10:45		Title: miRNA and Multiple Myeloma Drug Resistance Dr. Hong Chang, Professor, University of Toronto, Canada
10:45-11:00	Coffee Break
11:00-11:25		Title: Preferred Place of Death in Paediatric, Teenage and Young Adult Haemato-Oncology Patients: A Retrospective Review Dr. Philippa Anna Stilwell, National Medical Director's Clinical Fellow, University College London Hospital, UK
11:25-11:50		Title : Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) Intraocular Involvement: Clinicopathologic Characteristics and the Treatment Outcome of Intravitreal Injection of Methotrexate Dr. Wen-Bin Wei, Professor, Beijing Tongren Hospital, Capital Medical University, China
11:50-12:15		Speech Opportunity Available Abstract and Biography: Submit Here
12:15-12:40		Title: The Characteristics of EBV Transcriptome in Various Human Lymphomas Through Paired-End RNA Sequencing Mr. Nader Bayda,Limoges University and Hospital, France

Track 5-9: Melanoma/Skin Cancers

Time: 14:00-17:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Drs. Ponciano D. Cruz, Vice Chairman, University of Texas Southwestern Medical Center, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: DC-HIL/Gpnmb is a Target for Treating Metastatic Cancer and a Marker of Its Response to Immunotherapy Drs. Ponciano D. Cruz, Vice Chairman, University of Texas Southwestern Medical Center, USA
14:30-14:55		Title: Macrophage Hybridization with Melanoma Cells Promotes Metastasis Dr. John Pawelek, Senior Research Scientist, Yale University School of Medicine, USA
14:55-15:20		Title: Merkel Cell Carcinoma Update: The Case for Two Tumours Dr. A. Nirenberg, Director, Australasian College of Cutaneous Oncology, Australia
15:20-15:45		Title: Glucocorticoid Receptor Antagonism Overcomes Resistance to BRAF Inhibition in BRAF V600E-mutated Metastatic Melanoma Dr. Elena Obrador, Principal investigator and Associate Professor of Physiology at the University of Valencia, Spain
15:45-16:00	Coffee Break
16:00-16:25		Title: TBD Dr. Maria Manuela Gasper, University of Lisboa, Portugal
16:25-16:50		Title: TBD Dr. Robert A. Norman, the chief physician and owner, Dermatology Healthcare, USA
16:50-17:15		Title: TBD Dr. IC. Proietti, Sapienza University of Rome, Italy
17:15-17:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 5-10: Sarcoma

Time: 14:00-17:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Speech Opportunity Available Abstract and Biography: Submit Here
14:55-15:20		Speech Opportunity Available Abstract and Biography: Submit Here
15:20-15:45		Speech Opportunity Available Abstract and Biography: Submit Here
15:45-16:00	Coffee Break

Track 5-11: Pediatric Oncology

Time: 14:00-17:40, November 22, 2022 (Sunday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Title: Cognitive deficits and Psychopathological Symptoms Among Children with Medulloblastoma Annamária Szentes, Semmelweis University 2nd Department of Pediatrics, Hungary
14:55-15:20		Title: TBD Dr. Kam Lun Hon, The Chinese University of Hong Kong, Hong Kong
15:20-15:45		Title: Cardiotoxicity Among Adult Survivors Suffered from Childhood Malignancies Dr. Andreas C Petropoulos, Assistant Professor, Great Ormond Street Hospital, London, UK
15:45-16:00	Coffee Break

Track 6-4: Palliative & Critical Care

Time: 09:00-12:40, July 22, 2022 (Thursday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:00-09:05	Chair's Introduction
09:05-09:30		Speech Opportunity Available Abstract and Biography: Submit Here
09:30-09:55		Title: Common Oncologic Emergencies seen in the ED Dr. Maria Teresa Cruz Carreras, Associate Professor, Department of Emergency Medicine, MD Anderson Cancer Center, USA
09:55-10:20		Title: TBD Dr. Michelle Fleming, Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, UK
10:20-10:45		Title: TBD Dr. Hasan Mohammad Alkhudairi, King Saud University, Saudi Arabia
10:45-11:00	Coffee Break
11:00-11:25		Title: The Crucial Role of Sexuality During and Post Treatment for Oncology Patients and Those Who care for them Dr. Penny Daugherty, Oncology Nurse Navigator, Northside Hospital Cancer Institute, USA
11:25-11:50		Title : Anticipatory Grief and Burden of Family Caregivers of Patients with Advanced Cancer Ana Margarina Carrancha, Universidade do Porto, Portugal
11:50-12:15		Title : The influence of Spirituality on Decision-Making in Palliative Care Outpatients: A Cross-Sectional Study Dr. Francisca Rego, Universidade do Porto, Portugal
12:15-12:40		Speech Opportunity Available Abstract and Biography: Submit Here

Hosting Organization

World High Technology Society

Supporting Organization

WIN Consortium

The Society of Supportive Care in Oncology

International Honorary Chairmen

Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA

Overseas Cooperate Medias and Journals